| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.29 | 2e-09 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.32 | 3e-05 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |